These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study. Kelland MD; Freeman AS; LeWitt PA; Chiodo LA J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800 [TBL] [Abstract][Full Text] [Related]
28. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates. Byrnes EM; Bruno JP Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729 [TBL] [Abstract][Full Text] [Related]
29. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. Henry DJ; White FJ J Pharmacol Exp Ther; 1991 Sep; 258(3):882-90. PubMed ID: 1890623 [TBL] [Abstract][Full Text] [Related]
30. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
31. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Jiang HK; McGinty JF; Hong JS Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976 [TBL] [Abstract][Full Text] [Related]
32. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists. McPherson RJ; Marshall JF Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Engber TM; Marin C; Susel Z; Chase TN Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970 [TBL] [Abstract][Full Text] [Related]
35. Microiontophoretic studies of the effects of D-1 and D-2 receptor agonists on type I caudate nucleus neurons: lack of synergistic interaction. Shen RY; Asdourian D; Chiodo LA Synapse; 1992 Aug; 11(4):319-29. PubMed ID: 1354398 [TBL] [Abstract][Full Text] [Related]
36. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours. Fletcher GH; Starr MS Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970 [TBL] [Abstract][Full Text] [Related]
37. Effects of locally applied D1 and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions. Strömberg I; Bickford-Wimer P Brain Res; 1991 Nov; 564(2):279-85. PubMed ID: 1687374 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257 [TBL] [Abstract][Full Text] [Related]
39. Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists. Napier TC Synapse; 1992 Feb; 10(2):110-9. PubMed ID: 1350111 [TBL] [Abstract][Full Text] [Related]
40. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat. Simson PE; Johnson KB; Jurevics HA; Criswell HE; Napier TC; Duncan GE; Mueller RA; Breese GR J Pharmacol Exp Ther; 1992 Dec; 263(3):1454-63. PubMed ID: 1361576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]